<i>Lactobacillus reuteri</i> therapy to reduce side‐effects during anti‐<i>Helicobacter pylori</i> treatment in children: a randomized placebo controlled trial

Abstract

L. reuteri is capable of reducing frequency and intensity of antibiotic-associated side-effects during eradication therapy for H. pylori.